Previous Close | 2.89 |
1-Year Change | 62.36% |
6-Months Change | 86.45% |
3-Months Change | 45.23% |
Moving Avg (50d) | 2.7364 |
Moving Avg (200d) | 2.0147 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 70.9M |
Beta (3-Years) | 1.13 |
Revenue Growth (ttm) | 111.62% |
Net Profit Margin (ttm) | -272.67% |
Return On Assets (ttm) | -45.4% |
EPS (ttm) | -2.32 |
PE Ratio (ttm) | -1.25 |
Dividend Yield | 0% |
Asset Description: | Aadi Bioscience, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2025-01-29 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
2.948 | 3.035 | 3.092 | 3.179 | 3.324 | 3.468 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.